Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mapping of European activities on the integration of sex and gender factors in neurology and neuroscience.
Hentzen NB, Ferretti MT, Santuccione A, Jaarsma J, de Visser M, Moro E; Gender, Diversity Task force of the EAN; Hege Aamodt A, Arabia G, Aybeck S, Carvalho V, de Visser M, Teresa Ferretti M, Goudier R, Grisold W, Lebedeva ER, Jaarsma J, Matczack M, Magyari M, Judit Molnar M, Moro E, Rakusa M, Pajediene E, Tracy I, Vonck K. Hentzen NB, et al. Among authors: judit molnar m. Eur J Neurol. 2022 Jun 8. doi: 10.1111/ene.15439. Online ahead of print. Eur J Neurol. 2022. PMID: 35673956
Gender issues during the times of COVID-19 pandemic.
Grisold W, Moro E, Teresa Ferretti M, Hege Aamodt A, Arabia G, Lebedeva ER, Carvalho V, Rakusa M, Vonck K, Aybeck S, Hassan Mansour A, Goudier R, Giovannoni G, Jaarsma J, Judit Molnar M, Matczack M, Bassetti C, de Visser M; EAN Gender, Diversity Issues Task Force. Grisold W, et al. Among authors: judit molnar m. Eur J Neurol. 2021 Oct;28(10):e73-e77. doi: 10.1111/ene.14815. Epub 2021 Jun 25. Eur J Neurol. 2021. PMID: 33751757 Free PMC article. No abstract available.
Rare and Complex Urology: Clinical Overview of ERN eUROGEN.
Oomen L, Leijte E, Shilhan DE, Battye M; Members of ERN eUROGEN; Feitz WFJ. Oomen L, et al. Eur Urol. 2022 Feb;81(2):204-212. doi: 10.1016/j.eururo.2021.02.043. Epub 2021 Mar 18. Eur Urol. 2022. PMID: 33743996 Free article.
Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial.
Schoser B, Roberts M, Byrne BJ, Sitaraman S, Jiang H, Laforêt P, Toscano A, Castelli J, Díaz-Manera J, Goldman M, van der Ploeg AT, Bratkovic D, Kuchipudi S, Mozaffar T, Kishnani PS; PROPEL Study Group. Schoser B, et al. Lancet Neurol. 2021 Dec;20(12):1027-1037. doi: 10.1016/S1474-4422(21)00331-8. Lancet Neurol. 2021. PMID: 34800400 Clinical Trial.